Toxins (May 2022)

Treatment of Depression with Botulinum Toxin

  • Marc Axel Wollmer,
  • Michelle Magid,
  • Tillmann H. C. Kruger,
  • Eric Finzi

DOI
https://doi.org/10.3390/toxins14060383
Journal volume & issue
Vol. 14, no. 6
p. 383

Abstract

Read online

Injection of botulinum toxin (BoNT) into the glabellar region of the face is a novel therapeutic approach in the treatment of depression. This treatment method has several advantages, including few side effects and a long-lasting, depot-like effect. Here we review the clinical and experimental evidence for the antidepressant effect of BoNT injections as well as the theoretical background and possible mechanisms of action. Moreover, we provide practical instructions for the safe and effective application of BoNT in the treatment of depression. Finally, we describe the current status of the clinical development of BoNT as an antidepressant and give an outlook on its potential future role in the management of mental disorders.

Keywords